Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Amela Dizdarevic-Bostandzic"'
Autor:
Vanja Karlovic, Beslic, Azra, Burekovic, Zahida, Drace, Zelija, Velija-Asimi, Amela, Dizdarevic-Bostandzic
Publikováno v:
Materia Socio Medica. 34:92
Background: Polyglandular autoimmune syndrome type III (PAS III) is combination two most common autoimmune disease: Diabetes mellytus type 1 (DM1) and autoimmune thyroid disease (AITD). Objectives: The aims of the study were a) to define conection be
Autor:
Amela Dizdarevic, Bostandzic, Vanja Karlovic, Beslic, Ismana, Surkovic, Sefkija, Balic, Tanja, Dujic, Zelija Velija, Asimi, Azra, Burekovic
Publikováno v:
Medical Archives. 76:96
IDegLira( fixed combination of GLP 1 receptor agonist and insulin) has been shown to be effective in improving the glucoregulation in patients previously treated with oral therapy as well as individual components, GLP-1 receptor agonist or basal insu
Autor:
Amina Godinjak, Zelija Velija-Asimi, Ermin Begovic, Azra Burekovic, Amela Dizdarevic-Bostandzic, Vanja Karlovic
Publikováno v:
Medical Archives
Introduction: Diabetes mellitus(DM) is considered an independent cardiovascular risk factor. Having in mind concomitant occurence of diabetes and other cardiovascular risk factors, it is expected that patients with poor glucoregulation will have more
Autor:
Selma Jusufovic, Amela Dizdarevic-Bostandzic, Selma Gicić, Azra Burekovic, Zelija Velija-Asimi, Amina Godinjak, Amer Iglica, Adis Kukuljac
Publikováno v:
The Turkish Journal of Endocrinology and Metabolism. 21:37-41
Publikováno v:
Endocrine Abstracts.
Publikováno v:
Endocrine Abstracts.
Publikováno v:
Endocrine Abstracts.
Publikováno v:
Medical Archives
Introduction: Diabetes mellitus, the most frequent endocrinology disease is a predisposing factor for infections. Diabetic patients have 4,4 times greater risk of systemic infection than non diabetics. Aim: a) To determine the prevalence and characte
The effects of dipeptidyl peptidase-4 inhibitors in treatment of obese patients with type 2 diabetes
Autor:
Jozo Coric, Amela Dizdarevic-Bostandzic, Zelija Velija-Asimi, Jasenko Karamehic, Amra Macic-Dzankovic, Sebija Izetbegovic, Jasminka Djelilovic-Vranic, Mirsad Panjeta
Publikováno v:
Medical archives (Sarajevo, Bosnia and Herzegovina). 67(5)
Introduction: Dipeptidyl peptidase-4 (DPP-4) inhibitors are a new class of antihyperglycemic drugs that block degradation of incretin hormones. Goal: To assess the effects of treatment with DPP-4 inhibitors on glucoregulation and body weight in obese
Autor:
Ismana Surkovic, Zulfo Godinjak, Amina Godinjak, Zelija Velija-Asimi, Azra Burekovic, Amela Dizdarevic-Bostandzic
Publikováno v:
Medical Archives. 66:409
Introduction: Women with Polycystic Ovary Syndrome (PCOS) are at increased risk for cardiovascular morbidity and metabolic disorders including: dyslipidaemia, hypertension, insulin resistance, gestational diabetes, type 2 diabetes, systemic inflammat